Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 9

1.

In vitro and in vivo characterization of three 68Ga- and 111In-labeled peptides for cholecystokinin receptor imaging.

Roosenburg S, Laverman P, Joosten L, Eek A, Rutjes FP, van Delft FL, Boerman OC.

Mol Imaging. 2012 Sep-Oct;11(5):401-7.

PMID:
22954184
2.

Radiolabelled peptides for oncological diagnosis.

Laverman P, Sosabowski JK, Boerman OC, Oyen WJ.

Eur J Nucl Med Mol Imaging. 2012 Feb;39 Suppl 1:S78-92. doi: 10.1007/s00259-011-2014-7. Review.

3.

Preclinical evaluation of radiolabeled DOTA-derivatized cyclic minigastrin analogs for targeting cholecystokinin receptor expressing malignancies.

von Guggenberg E, Rangger C, Sosabowski J, Laverman P, Reubi JC, Virgolini IJ, Decristoforo C.

Mol Imaging Biol. 2012 Jun;14(3):366-75. doi: 10.1007/s11307-011-0506-2.

PMID:
21732165
4.

Stabilized (111)in-labeled sCCK8 analogues for targeting CCK2-receptor positive tumors: synthesis and evaluation.

Roosenburg S, Laverman P, Joosten L, Eek A, Oyen WJ, de Jong M, Rutjes FP, van Delft FL, Boerman OC.

Bioconjug Chem. 2010 Apr 21;21(4):663-70. doi: 10.1021/bc900465y.

PMID:
20302291
5.

Radiolabeled CCK/gastrin peptides for imaging and therapy of CCK2 receptor-expressing tumors.

Roosenburg S, Laverman P, van Delft FL, Boerman OC.

Amino Acids. 2011 Nov;41(5):1049-58. doi: 10.1007/s00726-010-0501-y. Epub 2010 Mar 3. Review.

6.

Cyclic minigastrin analogues for gastrin receptor scintigraphy with technetium-99m: preclinical evaluation.

von Guggenberg E, Sallegger W, Helbok A, Ocak M, King R, Mather SJ, Decristoforo C.

J Med Chem. 2009 Aug 13;52(15):4786-93. doi: 10.1021/jm900400w.

PMID:
19591486
7.

Two peptide receptor ligands (99m)Tc-EDDA/HYNIC-Tyr(3)-octreotide and (99m)Tc-EDDA/HYNIC-(D)Glu-octagastrin for scintigraphy of medullary thyroid carcinoma.

Kosowicz J, Mikołajczak R, Czepczyński R, Ziemnicka K, Gryczyńska M, Sowiński J.

Cancer Biother Radiopharm. 2007 Oct;22(5):613-28.

PMID:
17979564
8.

Targeting of a CCK(2) receptor splice variant with (111)In-labelled cholecystokinin-8 (CCK8) and (111)In-labelled minigastrin.

Laverman P, Roosenburg S, Gotthardt M, Park J, Oyen WJ, de Jong M, Hellmich MR, Rutjes FP, van Delft FL, Boerman OC.

Eur J Nucl Med Mol Imaging. 2008 Feb;35(2):386-92. Epub 2007 Oct 13.

PMID:
17934729
9.

99mTc-labelled HYNIC-minigastrin with reduced kidney uptake for targeting of CCK-2 receptor-positive tumours.

von Guggenberg E, Dietrich H, Skvortsova I, Gabriel M, Virgolini IJ, Decristoforo C.

Eur J Nucl Med Mol Imaging. 2007 Aug;34(8):1209-18. Epub 2007 Feb 17.

PMID:
17308920

Supplemental Content

Support Center